Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer
Titel:
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer
Auteur:
Boyd, Lenka N.C. Ali, Mahsoem Puik, Jisce R. Comandatore, Annalisa Ginocchi, Laura Meijer, Laura L. Swijnenburg, Rutger-Jan Tartarini, Roberta Le Large, Tessa Y.S. Morelli, Luca Garajova, Ingrid Besselink, Marc G. Mambrini, Andrea Wilmink, Johanna W. Frampton, Adam E. van Laarhoven, Hanneke W.M. Giovannetti, Elisa Kazemier, Geert